AIM: The importance of sarcopenia in cardiovascular diseases has been recently demonstrated. This study aims to examine whether skeletal muscle mass (SMM), an important component of sarcopenia, is associated with an increased risk of poor outcome in patients after ST-segment elevation myocardial infarction (STEMI). METHODS: We measured SMM in 387 patients with STEMI using dual-energy X-ray absorptiometry. Patients were divided into low- and high-appendicular skeletal mass index (ASMI: appendicular SMM divided by height squared (kg/m2)) groups using the first quartile of ASMI (≤ 6.64 kg/m2 for men and ≤ 5.06 kg/m2 for women). All patients were followed up for the primary composite outcome of all-cause death, nonfatal myocardial infarction, nonfatal ischemic stroke, hospitalization for congestive heart failure, and unplanned revascularization. RESULTS: Low-ASMI group was older and had a more complex coronary lesion, a lower left ventricular ejection fraction, and a higher prevalence of Killip classification ≥ 2 than high-ASMI group. During a median follow-up of 33 months, the event rate was significantly higher in low-ASMI group than in high-ASMI group (24.7% vs 13.4%, log-rank p=0.001). Even after adjustment for patients' background, low ASMI was independently associated with the high risk of primary composite events (adjusted hazard ratio 2.06, 95% confidence interval 1.01- 4.19, p=0.04). In the subgroup analyses of male patients (n=315), the optimal cutoff point of ASMI for predicting primary composite outcome was 6.75 kg/m2, which was close to its first quartile value. CONCLUSIONS: Low ASMI is independently associated with poor outcome in patients with STEMI.
AIM: The importance of sarcopenia in cardiovascular diseases has been recently demonstrated. This study aims to examine whether skeletal muscle mass (SMM), an important component of sarcopenia, is associated with an increased risk of poor outcome in patients after ST-segment elevation myocardial infarction (STEMI). METHODS: We measured SMM in 387 patients with STEMI using dual-energy X-ray absorptiometry. Patients were divided into low- and high-appendicular skeletal mass index (ASMI: appendicular SMM divided by height squared (kg/m2)) groups using the first quartile of ASMI (≤ 6.64 kg/m2 for men and ≤ 5.06 kg/m2 for women). All patients were followed up for the primary composite outcome of all-cause death, nonfatal myocardial infarction, nonfatal ischemic stroke, hospitalization for congestive heart failure, and unplanned revascularization. RESULTS: Low-ASMI group was older and had a more complex coronary lesion, a lower left ventricular ejection fraction, and a higher prevalence of Killip classification ≥ 2 than high-ASMI group. During a median follow-up of 33 months, the event rate was significantly higher in low-ASMI group than in high-ASMI group (24.7% vs 13.4%, log-rank p=0.001). Even after adjustment for patients' background, low ASMI was independently associated with the high risk of primary composite events (adjusted hazard ratio 2.06, 95% confidence interval 1.01- 4.19, p=0.04). In the subgroup analyses of male patients (n=315), the optimal cutoff point of ASMI for predicting primary composite outcome was 6.75 kg/m2, which was close to its first quartile value. CONCLUSIONS: Low ASMI is independently associated with poor outcome in patients with STEMI.
Entities:
Keywords:
ST-segment elevation myocardial infarction; Sarcopenia; Skeletal muscle mass
Authors: Andreas Egger; David Niederseer; Gernot Diem; Thomas Finkenzeller; E Ledl-Kurkowski; Rosemarie Forstner; Christian Pirich; Wolfgang Patsch; Raimund Weitgasser; Josef Niebauer Journal: Eur J Prev Cardiol Date: 2012-05-25 Impact factor: 7.804
Authors: Thomas S G Sehested; Tine W Hansen; Michael H Olsen; Steen Z Abildstrøm; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Sten Madsbad; Jørgen Jeppesen Journal: Eur J Cardiovasc Prev Rehabil Date: 2010-08
Authors: Carl J Lavie; Paul A McAuley; Timothy S Church; Richard V Milani; Steven N Blair Journal: J Am Coll Cardiol Date: 2014-02-12 Impact factor: 24.094
Authors: Fanny Buckinx; Francesco Landi; Matteo Cesari; Roger A Fielding; Marjolein Visser; Klaus Engelke; Stefania Maggi; Elaine Dennison; Nasser M Al-Daghri; Sophie Allepaerts; Jurgen Bauer; Ivan Bautmans; Maria Luisa Brandi; Olivier Bruyère; Tommy Cederholm; Francesca Cerreta; Antonio Cherubini; Cyrus Cooper; Alphonso Cruz-Jentoft; Eugene McCloskey; Bess Dawson-Hughes; Jean-Marc Kaufman; Andrea Laslop; Jean Petermans; Jean-Yves Reginster; René Rizzoli; Sian Robinson; Yves Rolland; Ricardo Rueda; Bruno Vellas; John A Kanis Journal: J Cachexia Sarcopenia Muscle Date: 2018-01-19 Impact factor: 12.910
Authors: Jared W Skinner; Dana M Otzel; Andrew Bowser; Daniel Nargi; Sanjay Agarwal; Mark D Peterson; Baiming Zou; Stephen E Borst; Joshua F Yarrow Journal: J Cachexia Sarcopenia Muscle Date: 2018-03-15 Impact factor: 12.910
Authors: Ana Paula Trussardi Fayh; Francisco Felipe de Oliveira Guedes; Guilherme Carlos Filgueira Calado; Sandra Azevedo Queiroz; Marina Gabriely Gomes Barbosa Anselmo; Iasmin Matias de Sousa Journal: Nutrients Date: 2022-07-30 Impact factor: 6.706